Remdesivir-Induced Symptomatic Bradycardia in the Treatment of COVID-19 Disease

Authors

Jomel Jacinto, HCA HealthcareFollow
Milan Patel, HCA HealthcareFollow
Justin Hao Goh, HCA HealthcareFollow
Kenneth Yamamura, HCA HealthcareFollow

Division

West Florida

Hospital

Regional Medical Center Bayonet Point

Document Type

Case Report

Publication Date

5-2021

Keywords

Bradycardia, Cardiogenic shock, COVID-19, Novel coronavirus disease 2019, Remdesivir

Disciplines

Cardiology | Infectious Disease | Internal Medicine | Virus Diseases

Abstract

No abstract available.

Publisher or Conference

Heart Rhythm Case Reports

Recommended Citation

Jacinto JP, Patel M, Goh J, Yamamura K. Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease. Preprint. HeartRhythm Case Rep. 2021;():. https://doi.org/10.1016/j.hrcr.2021.05.004